<DOC>
	<DOCNO>NCT00350090</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety PROCRIT ( Epoetin alfa ) administer 40,000 Units weekly cancer patient receive chemotherapy radiation therapy .</brief_summary>
	<brief_title>A Study Assess Response Rate PROCRIT ( Epoetin Alfa ) Given Dose 40,000 Units Once Week Cancer Patients With Anemia Who Are Not Receiving Chemotherapy .</brief_title>
	<detailed_description>This open-label ( researcher patient study know treatment give ) , non-randomized , multi-center pilot study objective investigate efficacy PROCRIT ( Epoetin alfa ) regard hematopoietic response administer 40,000 Units subcutaneously ( skin ) per week anemic patient cancer receive chemotherapy radiation therapy . Hematological laboratory test ( hemoglobin hematocrit ) , vital sign ( blood pressure ) occurrence severity adverse event assess throughout study . Patients receive PROCRIT ( Epoetin alfa ) injection ( 40,000 Units per injection ) skin every week maximum 13 week . Doses may reduce depend patient ' hemoglobin level .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Histologically confirm diagnosis nonmyeloid malignancy Baseline hemoglobin value le equal 11 g/dL unrelated transfusion Patients must receive plan receive chemotherapy radiotherapy within 16week study period . However , patient receive hormonal therapy nonmyelosuppressive therapy allowable Female patient reproductive potential must negative serum pregnancy test screening . Uncontrolled hypertension History ( within 6 month ) uncontrolled cardiac arrhythmia , history pulmonary embolus , deep vein thrombosis , ischemic stroke , arterial venous thrombotic event ( exclude superficial thromboses ) , know history chronic coagulation disorder Transfusion within 28 day prior first dose Planned chemotherapy radiation study prior chemotherapy within 8 week radiation within 4 week study entry No prior treatment Epoetin alfa erythropoietic agent within previous two month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Hemoglobin value</keyword>
</DOC>